Loading…
Genetic Variations, Triglycerides, and Atherosclerotic Disease
[See article vol. 26: 136-144] [Understandings from Causal Associations between Biomarkers and Clinical Outcomes] To establish a causal association between a biomarker and an outcome, randomized controlled trials (RCT) are the gold standard. On the other hand, the Mendelian randomization trial is a...
Saved in:
Published in: | Journal of Atherosclerosis and Thrombosis 2019/02/01, Vol.26(2), pp.128-131 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [See article vol. 26: 136-144] [Understandings from Causal Associations between Biomarkers and Clinical Outcomes] To establish a causal association between a biomarker and an outcome, randomized controlled trials (RCT) are the gold standard. On the other hand, the Mendelian randomization trial is a technique that uses genotypes as instruments to assess causal associations between biomarkers and outcomes. In a Mendelian randomization trial, a genetic variant associated with a particular biomarker is used as a proxy for the biomarker. Outcomes are compared between the group with the effect allele and a group with the reference allele. This approach can be considered a proxy for an RCT, in which the randomized groups have similar confounding variables. Accordingly, a Mendelian randomization trial can be regarded as a natural RCT. Using this technique, a causal association between LDL cholesterol and atherosclerotic diseases have been firmly confirmed. With respect to triglycerides, they have been associated with atherosclerotic diseases in numerous epidemiological studies. |
---|---|
ISSN: | 1340-3478 1880-3873 1880-3873 |
DOI: | 10.5551/jat.ED102 |